FDA clears new ReWalk product for stroke survivors

JNS original reporting, analysis and opinion pieces are available for republication. Articles not produced by JNS, as identified in the byline, are not eligible for republication.

We offer a limited trial license that allows publishers to republish up to three JNS articles, online or in print, at no cost. JNS retains any and all right, title and interest in all of its intellectual property and other rights.

To republish, copy the HTML using the button provided. This includes the JNS tracking pixel, all paragraph styling and hyperlinks, the author byline and clear credit to Jewish News Syndicate (JNS), all of which must be included in the republished article.

Images and video content are not included in the HTML code or article text, but you are authorized to use photographs from the following sources: Flash90, public domain, Creative Commons licensed images, and any photographs credited to JNS, provided that all applicable attribution and licensing conditions are observed.

If you’re interested in republishing JNS content on a regular basis, complete this form to get started.